Novel Insights into the Protective Properties of ACTH<sub>(4-7)</sub>PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia–Reperfusion in Rats

Cerebral ischaemia is the most common cause of impaired brain function. Biologically active peptides represent potential drugs for reducing the damage that occurs after ischaemia. The synthetic melanocortin derivative, ACTH<sub>(4-7)</sub>PGP (Semax), has been used successfully in the tr...

Full description

Bibliographic Details
Main Authors: Ivan B. Filippenkov, Vasily V. Stavchansky, Alina E. Denisova, Vadim V. Yuzhakov, Larisa E. Sevan’kaeva, Olga Y. Sudarkina, Veronika G. Dmitrieva, Leonid V. Gubsky, Nikolai F. Myasoedov, Svetlana A. Limborska, Lyudmila V. Dergunova
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/11/6/681
_version_ 1797564428488540160
author Ivan B. Filippenkov
Vasily V. Stavchansky
Alina E. Denisova
Vadim V. Yuzhakov
Larisa E. Sevan’kaeva
Olga Y. Sudarkina
Veronika G. Dmitrieva
Leonid V. Gubsky
Nikolai F. Myasoedov
Svetlana A. Limborska
Lyudmila V. Dergunova
author_facet Ivan B. Filippenkov
Vasily V. Stavchansky
Alina E. Denisova
Vadim V. Yuzhakov
Larisa E. Sevan’kaeva
Olga Y. Sudarkina
Veronika G. Dmitrieva
Leonid V. Gubsky
Nikolai F. Myasoedov
Svetlana A. Limborska
Lyudmila V. Dergunova
author_sort Ivan B. Filippenkov
collection DOAJ
description Cerebral ischaemia is the most common cause of impaired brain function. Biologically active peptides represent potential drugs for reducing the damage that occurs after ischaemia. The synthetic melanocortin derivative, ACTH<sub>(4-7)</sub>PGP (Semax), has been used successfully in the treatment of patients with severe impairment of cerebral blood circulation. However, its molecular mechanisms of action within the brain are not yet fully understood. Previously, we used the transient middle cerebral artery occlusion (tMCAO) model to study the damaging effects of ischaemia–reperfusion on the brain transcriptome in rats. Here, using RNA-Seq analysis, we investigated the protective properties of the Semax peptide at the transcriptome level under tMCAO conditions. We have identified 394 differentially expressed genes (DEGs) (>1.5-fold change) in the brains of rats at 24 h after tMCAO treated with Semax relative to saline. Following tMCAO, we found that Semax suppressed the expression of genes related to inflammatory processes and activated the expression of genes related to neurotransmission. In contrast, ischaemia–reperfusion alone activated the expression of inflammation-related genes and suppressed the expression of neurotransmission-related genes. Therefore, the neuroprotective action of Semax may be associated with a compensation of mRNA expression patterns that are disrupted during ischaemia–reperfusion conditions.
first_indexed 2024-03-10T18:57:12Z
format Article
id doaj.art-4c4c777741c1402bb0f0c69164154a6d
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-10T18:57:12Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-4c4c777741c1402bb0f0c69164154a6d2023-11-20T04:38:49ZengMDPI AGGenes2073-44252020-06-0111668110.3390/genes11060681Novel Insights into the Protective Properties of ACTH<sub>(4-7)</sub>PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia–Reperfusion in RatsIvan B. Filippenkov0Vasily V. Stavchansky1Alina E. Denisova2Vadim V. Yuzhakov3Larisa E. Sevan’kaeva4Olga Y. Sudarkina5Veronika G. Dmitrieva6Leonid V. Gubsky7Nikolai F. Myasoedov8Svetlana A. Limborska9Lyudmila V. Dergunova10Institute of Molecular Genetics, Russian Academy of Sciences, 123182 Moscow, RussiaInstitute of Molecular Genetics, Russian Academy of Sciences, 123182 Moscow, RussiaPirogov Russian National Research Medical University, Federal Center of Cerebrovascular Pathology and Stroke, Ministry of Health Care of Russian Federation, 117342 Moscow, RussiaA. Tsyb Medical Radiological Research Center–Branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, 249031 Obninsk, RussiaA. Tsyb Medical Radiological Research Center–Branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, 249031 Obninsk, RussiaInstitute of Molecular Genetics, Russian Academy of Sciences, 123182 Moscow, RussiaInstitute of Molecular Genetics, Russian Academy of Sciences, 123182 Moscow, RussiaPirogov Russian National Research Medical University, Federal Center of Cerebrovascular Pathology and Stroke, Ministry of Health Care of Russian Federation, 117342 Moscow, RussiaInstitute of Molecular Genetics, Russian Academy of Sciences, 123182 Moscow, RussiaInstitute of Molecular Genetics, Russian Academy of Sciences, 123182 Moscow, RussiaInstitute of Molecular Genetics, Russian Academy of Sciences, 123182 Moscow, RussiaCerebral ischaemia is the most common cause of impaired brain function. Biologically active peptides represent potential drugs for reducing the damage that occurs after ischaemia. The synthetic melanocortin derivative, ACTH<sub>(4-7)</sub>PGP (Semax), has been used successfully in the treatment of patients with severe impairment of cerebral blood circulation. However, its molecular mechanisms of action within the brain are not yet fully understood. Previously, we used the transient middle cerebral artery occlusion (tMCAO) model to study the damaging effects of ischaemia–reperfusion on the brain transcriptome in rats. Here, using RNA-Seq analysis, we investigated the protective properties of the Semax peptide at the transcriptome level under tMCAO conditions. We have identified 394 differentially expressed genes (DEGs) (>1.5-fold change) in the brains of rats at 24 h after tMCAO treated with Semax relative to saline. Following tMCAO, we found that Semax suppressed the expression of genes related to inflammatory processes and activated the expression of genes related to neurotransmission. In contrast, ischaemia–reperfusion alone activated the expression of inflammation-related genes and suppressed the expression of neurotransmission-related genes. Therefore, the neuroprotective action of Semax may be associated with a compensation of mRNA expression patterns that are disrupted during ischaemia–reperfusion conditions.https://www.mdpi.com/2073-4425/11/6/681tMCAOmRNA expressionRNA-Seqsynthetic melanocortin derivative ACTH<sub>(4-7)</sub>PGP (Semax)peptide regulation
spellingShingle Ivan B. Filippenkov
Vasily V. Stavchansky
Alina E. Denisova
Vadim V. Yuzhakov
Larisa E. Sevan’kaeva
Olga Y. Sudarkina
Veronika G. Dmitrieva
Leonid V. Gubsky
Nikolai F. Myasoedov
Svetlana A. Limborska
Lyudmila V. Dergunova
Novel Insights into the Protective Properties of ACTH<sub>(4-7)</sub>PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia–Reperfusion in Rats
Genes
tMCAO
mRNA expression
RNA-Seq
synthetic melanocortin derivative ACTH<sub>(4-7)</sub>PGP (Semax)
peptide regulation
title Novel Insights into the Protective Properties of ACTH<sub>(4-7)</sub>PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia–Reperfusion in Rats
title_full Novel Insights into the Protective Properties of ACTH<sub>(4-7)</sub>PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia–Reperfusion in Rats
title_fullStr Novel Insights into the Protective Properties of ACTH<sub>(4-7)</sub>PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia–Reperfusion in Rats
title_full_unstemmed Novel Insights into the Protective Properties of ACTH<sub>(4-7)</sub>PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia–Reperfusion in Rats
title_short Novel Insights into the Protective Properties of ACTH<sub>(4-7)</sub>PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia–Reperfusion in Rats
title_sort novel insights into the protective properties of acth sub 4 7 sub pgp semax peptide at the transcriptome level following cerebral ischaemia reperfusion in rats
topic tMCAO
mRNA expression
RNA-Seq
synthetic melanocortin derivative ACTH<sub>(4-7)</sub>PGP (Semax)
peptide regulation
url https://www.mdpi.com/2073-4425/11/6/681
work_keys_str_mv AT ivanbfilippenkov novelinsightsintotheprotectivepropertiesofacthsub47subpgpsemaxpeptideatthetranscriptomelevelfollowingcerebralischaemiareperfusioninrats
AT vasilyvstavchansky novelinsightsintotheprotectivepropertiesofacthsub47subpgpsemaxpeptideatthetranscriptomelevelfollowingcerebralischaemiareperfusioninrats
AT alinaedenisova novelinsightsintotheprotectivepropertiesofacthsub47subpgpsemaxpeptideatthetranscriptomelevelfollowingcerebralischaemiareperfusioninrats
AT vadimvyuzhakov novelinsightsintotheprotectivepropertiesofacthsub47subpgpsemaxpeptideatthetranscriptomelevelfollowingcerebralischaemiareperfusioninrats
AT larisaesevankaeva novelinsightsintotheprotectivepropertiesofacthsub47subpgpsemaxpeptideatthetranscriptomelevelfollowingcerebralischaemiareperfusioninrats
AT olgaysudarkina novelinsightsintotheprotectivepropertiesofacthsub47subpgpsemaxpeptideatthetranscriptomelevelfollowingcerebralischaemiareperfusioninrats
AT veronikagdmitrieva novelinsightsintotheprotectivepropertiesofacthsub47subpgpsemaxpeptideatthetranscriptomelevelfollowingcerebralischaemiareperfusioninrats
AT leonidvgubsky novelinsightsintotheprotectivepropertiesofacthsub47subpgpsemaxpeptideatthetranscriptomelevelfollowingcerebralischaemiareperfusioninrats
AT nikolaifmyasoedov novelinsightsintotheprotectivepropertiesofacthsub47subpgpsemaxpeptideatthetranscriptomelevelfollowingcerebralischaemiareperfusioninrats
AT svetlanaalimborska novelinsightsintotheprotectivepropertiesofacthsub47subpgpsemaxpeptideatthetranscriptomelevelfollowingcerebralischaemiareperfusioninrats
AT lyudmilavdergunova novelinsightsintotheprotectivepropertiesofacthsub47subpgpsemaxpeptideatthetranscriptomelevelfollowingcerebralischaemiareperfusioninrats